INBX

Inhibrx Biosciences, Inc.

Biotechnology · Biotechnology

$219.90 sample

+1.81 (+0.83%) 1D

Market cap

$1.31T

Price as of

2026-10-15

Latest filing

8-K · 2026-09-22

Alerts

8

Price$219.90 +12.73% 3M daily closessample

219.90189.63

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09INSInsider sell: Chief Executive Officer
Oct 01INSInsider buy: 10% owner
Sep 22SEC10-Q filed
Sep 17SECDEF 14A filed
Sep 14INSInsider sell: EVP, Operations
Sep 07SECForm 144 filed
Aug 28SECDEF 14A filed
Aug 19SEC10-Q filed

Sign up to see the real INBX record →

Company facts

SEC EDGAR registration

Name: Inhibrx Biosciences, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +9sample, -100 to +100
Reporting currency: USD

Who is positioning in INBX

sample

Insiders: 27 insider transactions over 90 days, net selling, $900.4M
Congress: 5 members traded over 90 days
Institutions · 13F: 11 funds hold $6.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$73.9B +17.4% y/y

Q4 2024Q3 2026

Inventory$45.1B +13.3% y/y

Q4 2024Q3 2026

Accounts receivable$32.6B +7.8% y/y

Q4 2024Q3 2026

Total debt$91.5B +12.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $586.0B -0.7% 3M
Sample peer B: $1.25T -13.0% 3M
Sample peer C: $238.9B +14.3% 3M
Sample peer D: $518.1B -8.8% 3M
Sample peer E: $1.14T -2.8% 3M